MedTrace Logo

Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort

NCT04396912 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-05-21

No results posted yet for this study

Summary

In the present study, the severity of recurrent laryngeal nerve injury (RLNI) and hypocalcemia (H) will be followed-up and the probable interrelation between them will be proposed considering the clinical situation of patients, e.g. improvement in hypocalcemia also make a positive effect on voice? (any objective sign? Ca? PTH?), return of voice is parallel with the improvement in hypocalcemia? Postoperative calcium (Ca), parathyroid hormone (PTH), regular vocal cord evaluations by ear-nose-throat (ENT) exams, deterioration-stability-improvement of clinical symptoms regarding both Ca metabolism and vocal cord function will be noted at regular intervals (postoperative day 1-3-first, weekly control/first month, monthly/first 6-month, 3-monthly/6-12 months) at outpatient controls. Serum Ca, PTH, ENT evaluation of vocal cords-noted.

Conditions

  • Iatrogenic Hypocalcemia
  • Iatrogenic Hypoparathyroidism
  • Vocal Cord Paralysis
  • Vocal Cord Paresis
  • Vocal Cord; Injury, Superficial
  • Thyroid Cancer, Papillary
  • Thyroid Cancer
  • Multinodular Goiter
  • Thyroid Neoplasms
  • Thyroid Nodule
  • Calcium Deficiency
  • PTH

Interventions

PROCEDURE

Total thyroidectomy

Patients with thyroid diseases either benign (e.g. multinodular goitre) or malign (e.g. thyroid carcinoma) will be prepared for total thyroidectomy procedure and will be enrolled.

Sponsors & Collaborators

  • Umraniye Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Sema YUKSEKDAG, MD · Instructor in General Surgery

  • Ethem UNAL, MD, PhD, USMLE & IFSO-Certified, Board CSS · Assoc. Professor of General Surgery and Surgical Oncology

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396912 on ClinicalTrials.gov